3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Glioblastoma
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Lymphoid Interstitial Pneumonia
2
Liposarcoma
2
Interventions
pembrolizumab
3
lenvatinib
2
Specimen Handling
2
Nivolumab
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
atezolizumab
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Gemcitabine
1
Doxorubicin
1
Dehydroepiandrosterone
1
CTLA-4 Antigen
1
Bupropion
1
Blood Specimen Collection
1
Bevacizumab
1
Axitinib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
Immunoglobulin G
×
90 days
×
Clear all
No trials found.